Rubicon Organics Second Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.002 loss in 2Q 2023)

Rubicon Organics (CVE:ROMJ) Second Quarter 2024 Results

Key Financial Results

• Revenue: CA$12.1m (up 7.3% from 2Q 2023).
• Net loss: CA$454.2k (loss widened by 299% from 2Q 2023).
• CA$0.008 loss per share (further deteriorated from CA$0.002 loss in 2Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Rubicon Organics Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada.

Performance of the Canadian Pharmaceuticals industry.

The company's shares are down 8.3% from a week ago.

Risk Analysis

You should learn about the 3 warning signs we've spotted with Rubicon Organics.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.